Get Your Personalized Supplement StackSupplement Stack Quiz

Oxo Vanadium

Also known as: Vanadium supplements, vanadyl sulfate, bis(ethylmaltolato)oxovanadium(IV), bis(bismaltolato)oxovanadium(IV), VO^2+, BEOV, BMOV, Oxo Vanadium

Overview

Oxo vanadium refers to synthetic vanadium compounds, primarily in oxidation states +4 or +5, such as vanadyl sulfate, bis(ethylmaltolato)oxovanadium(IV) (BEOV), and bis(bismaltolato)oxovanadium(IV) (BMOV). These compounds are investigated as trace mineral supplements, particularly for their proposed insulin-mimetic and metabolic effects. They are not naturally abundant in food but are chemically derived. Primary research focuses on their potential for glycemic control in diabetes mellitus (both type 1 and type 2), modulation of lipid metabolism, and possible anti-inflammatory and antioxidant properties. Vanadium compounds are believed to mimic insulin by influencing glucose uptake, glycogen synthesis, and lipid metabolism, and they possess redox activity. Research is predominantly preclinical, with limited but growing human clinical trial data, indicating moderate to low certainty of evidence.

Benefits

Oxo vanadium compounds have shown promising effects, primarily in animal models of diabetes. Animal studies consistently demonstrate that vanadium compounds can reduce hyperglycemia, improve insulin sensitivity, decrease glucosuria, and normalize lipid profiles by reducing triglycerides and total cholesterol while increasing HDL. These effects are significant for glycemic and lipid parameters in diabetic animals. Secondary benefits observed in animal models include anti-inflammatory and antioxidant effects, reducing biomarkers of oxidative stress and inflammation, and improvements in bone metabolism with BEOV supplementation. In humans, a network meta-analysis of 170 RCTs suggested vanadium supplements might be effective for lowering total cholesterol in type 2 diabetes, ranking them best among various micronutrients for this specific outcome, although the certainty of this evidence is very low. Benefits are primarily studied in diabetic populations, with no established benefits in non-diabetic individuals. Effects in animal studies typically manifest over weeks to months, with human RCT durations varying.

How it works

Oxo vanadium compounds exert their effects primarily by mimicking insulin. They activate insulin receptor tyrosine kinase and subsequent downstream signaling pathways, which enhances glucose uptake and promotes glycogen synthesis in cells. A key mechanism involves the inhibition of protein tyrosine phosphatases, which prolongs the activation of the insulin receptor. This action impacts the liver, muscle, and adipose tissue, leading to improved glucose metabolism. Additionally, oxo vanadium modulates lipid metabolism by reducing the release of free fatty acids and decreasing very-low-density lipoprotein (VLDL) synthesis. Known molecular targets include the insulin receptor, protein tyrosine phosphatases, glucose transporters (GLUT4), and enzymes involved in glycogen synthesis and lipogenesis. Oral bioavailability is generally low and variable, with organic complexes like BEOV showing improved absorption compared to inorganic salts.

Side effects

Oxo vanadium supplements have a narrow therapeutic window, meaning the difference between an effective dose and a toxic dose is small, raising significant toxicity concerns, especially at higher doses. Common side effects reported in some human studies include gastrointestinal discomfort, nausea, and diarrhea. Less common but more serious side effects, observed in animal data and case reports, include potential nephrotoxicity (kidney damage) and hepatotoxicity (liver damage) with prolonged or high-dose use. Rare side effects may include oxidative damage due to the compound's redox activity, though allergic reactions are uncommon. Oxo vanadium can interact with antidiabetic medications, potentially affecting glycemic control, and caution is advised. It is contraindicated in patients with kidney or liver impairment due to the risk of accumulation and increased toxicity. Safety in special populations such as pregnant or lactating women, children, and the elderly is not well established.

Dosage

The minimum effective dose for oxo vanadium is not well defined, and human doses in clinical trials have varied widely, typically ranging from 50 to 150 mg of elemental vanadium daily. However, no consensus exists on an optimal dosage range. The maximum safe dose is also not firmly established, but doses exceeding 100 mg/day may increase the risk of toxicity. Oxo vanadium is typically administered orally, often in divided doses, to potentially improve absorption and minimize gastrointestinal side effects. Organic vanadium complexes, such as bis(ethylmaltolato)oxovanadium (BEOV) and bis(bismaltolato)oxovanadium (BMOV), are generally preferred due to their improved bioavailability and potentially lower toxicity compared to inorganic salts. Food intake may reduce absorption, while an acidic environment might enhance solubility. There are no established cofactors required for its action, though antioxidant support may help mitigate potential oxidative stress.

FAQs

Is oxo vanadium safe for long-term use?

Long-term safety of oxo vanadium is unclear due to potential toxicity and a narrow therapeutic window. Caution and medical supervision are warranted for any extended use.

Does oxo vanadium replace insulin or diabetes medications?

No, oxo vanadium is currently an investigational adjunct and should not be used as a replacement for insulin or prescribed diabetes medications. Always consult a healthcare professional.

How soon can benefits be expected?

Animal studies show effects within weeks, but human data are limited and variable. The time course for observable benefits in humans is not well established.

Can oxo vanadium cause heavy metal poisoning?

Yes, at high doses or with prolonged use, oxo vanadium can lead to toxicity, including potential kidney and liver damage. Monitoring by a healthcare professional is essential.

Are all vanadium supplements the same?

No, the chemical form of vanadium significantly affects its bioavailability and safety profile. Organic complexes generally have better absorption and potentially lower toxicity than inorganic salts.

Research Sources

https://hpp.tbzmed.ac.ir/FullHtml/hpp-37228 – This systematic review of animal studies (1990–2021) found that vanadium compounds improved biomarkers of inflammation and oxidative stress in diabetic animals. While showing promise, the review noted a minor risk of bias in some studies and highlighted the uncertainty of clinical relevance due to the exclusive focus on animal data.
https://pdfs.semanticscholar.org/e0c7/209fd14bbd54b3627b9ef2142f45bedc5da4.pdf – This systematic review, encompassing animal models and in vitro studies, concluded that vanadium compounds effectively improved glycemic control, lipid metabolism, and bone metabolism in diabetic animals. It provided comprehensive preclinical data but acknowledged the significant limitation of a lack of large-scale human randomized controlled trials.
https://pubmed.ncbi.nlm.nih.gov/36638933/ – This network meta-analysis of 170 randomized controlled trials involving 14,223 patients with type 2 diabetes indicated that vanadium supplements ranked best for lowering total cholesterol. However, the study emphasized that the certainty of this evidence was very low, and other micronutrients showed better efficacy for glucose control, highlighting significant heterogeneity and indirect evidence.
https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2008.634 – This EFSA scientific opinion discusses the safety and bioavailability of vanadium compounds. It highlights that the oral bioavailability of vanadium is low and variable, with organic complexes like bis(ethylmaltolato)oxovanadium showing improved absorption compared to inorganic salts. The report underscores the importance of chemical form for both efficacy and safety.
https://www.ncbi.nlm.nih.gov/books/NBK76434/ – This source provides general information on vanadium, including its classification as a trace mineral and its potential roles in biological systems. It implicitly supports the understanding of vanadium's basic properties and its consideration as a metal-based supplement, aligning with the broader context of oxo vanadium research.